MEK inhibitors raise the susceptibility of melanoma cells to cytotoxic T cell (CTL) lysis partly due to increased manifestation of melanocyte differentiation antigens such as for example MART-1/melan-A and gp100 (30)
MEK inhibitors raise the susceptibility of melanoma cells to cytotoxic T cell (CTL) lysis partly due to increased manifestation of…